Injective INJ
Rank #97Injective Overview
As of September 22, 2026, Injective (INJ) is trading at $7.67, down 1.26% over the past 24 hours. It ranks #97 by market capitalisation, currently valued at $749.28M, on $150.77M of trading volume in the last 24 hours.
Injective Price Chart Binance
Performance
Market Metrics
Technical Analysis live indicator readings
Moving Averages
Oscillators
Support & Resistance daily pivot levels
All indicators are computed from Binance daily OHLC. This is a summary of current technical readings (overbought/oversold & trend model) — not a price forecast, and not investment advice.
Correlations 90-day, vs majors
Pearson correlation of daily returns over the last 90 days (Binance). +1 moves together, 0 unrelated, −1 moves opposite.
Derivatives Hyperliquid perps
Markets Binance spot
| Pair | Price | 24h Volume |
|---|---|---|
| INJ/USDT | $7.69 | ≈ $22.12M |
| INJ/USDC | $7.70 | ≈ $2.58M |
| INJ/TRY | 374.7 TRY | ≈ $1.79M |
| INJ/TUSD | $26.23 | ≈ $550.2K |
| INJ/ETH | 0.001559 ETH | ≈ $525.3K |
| INJ/BNB | 0.004703 BNB | ≈ $516.9K |
| INJ/BTC | 0.00008909 BTC | ≈ $301.4K |
Live spot pairs on Binance, ranked by USD-equivalent 24-hour volume. For information only.
Price History last 30 days
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| Loading… | |||||
INJ Calculators
Injective Price in Other Currencies
Converted from USD at European Central Bank reference rates (frankfurter.app), updated daily.
Compare with Top Coins
| Coin | Price | 24h | Market Cap |
|---|---|---|---|
| BitcoinBTC | $85,899.17 | +1.68% | $1.73T |
| EthereumETH | $2,740.38 | +0.89% | $334.52B |
| TetherUSDT | $0.9996 | +0.04% | $183.31B |
| BNBBNB | $785.66 | +0.20% | $104.62B |
| XRPXRP | $1.53 | +3.63% | $96.50B |
| USDCUSDC | $0.9999 | +0.03% | $74.68B |
| SolanaSOL | $117.06 | +1.30% | $68.78B |
| InjectiveINJ | $7.67 | −1.26% | $749.28M |
Market Sentiment
Popular Injective searches
Market data is aggregated from public sources (Binance, CoinPaprika, Hyperliquid, Polymarket, alternative.me) for informational purposes only and may be delayed. This is not investment advice.